Atlas Trials

Immune Responses in Oncology Patients to Novel Coronavirus Vaccines (IROC)

Clinical trial NCT04930055 · TERMINATED

Trial details

NCT number
NCT04930055
Sponsor
Indiana University
Status
TERMINATED
Study type
OBSERVATIONAL
Cancer
Start date
2021-06-30
Primary completion
2021-11-01
Enrollment
2206

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.